Certara Unveils $100 Million Buyback Plan In Better-Than-Expected Preliminary Earnings Report
1. Certara expects Q1 revenue of $106 million, up 10% year-over-year. 2. CEO notes $100 million buyback underscores confidence in growth strategy. 3. Company launched Non-Animal Navigator for biopharma, enhancing market position. 4. Guidance for 2025 sales between $415 million to $425 million remains unchanged. 5. Stock rose 9.14% to $14.10, reflecting positive market reception.